Global Rheumatoid Arthritis Testing Market Growth (Status and Outlook) 2025-2031

Global Rheumatoid Arthritis Testing Market Growth (Status and Outlook) 2025-2031

The global Rheumatoid Arthritis Testing market size is predicted to grow from US$ 2667 million in 2025 to US$ 4071 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.

The rheumatoid arthritis (RA) testing market is experiencing growth, mainly due to the increase in the number of RA patients worldwide, the need for early diagnosis, and the continuous advancement of diagnostic technology. The main drivers of the market include technological advancement, the increase in the elderly population, the need for effective treatment options, and favorable health reimbursement policies. However, market growth also faces some challenges, such as test-related complications, the number of undiagnosed patients, and distrust of certain testing measures.

The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.

In addition, the RA treatment market is also showing a trend of diversified development, including the development of biological drugs and targeted therapies, which provide better efficacy and safety by precisely targeting specific immune system components and inflammatory pathways. However, safety issues related to RA treatment may hinder patient acceptance and limit market growth.

Overall, both the RA detection and treatment markets face huge growth potential, but also need to overcome some challenges, such as improving the reliability of detection, reducing costs, raising public awareness of RA, and ensuring the safety and effectiveness of treatment.

LPI (LP Information)' newest research report, the “Rheumatoid Arthritis Testing Industry Forecast” looks at past sales and reviews total world Rheumatoid Arthritis Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Rheumatoid Arthritis Testing sales for 2025 through 2031. With Rheumatoid Arthritis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rheumatoid Arthritis Testing industry.

This Insight Report provides a comprehensive analysis of the global Rheumatoid Arthritis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rheumatoid Arthritis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rheumatoid Arthritis Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rheumatoid Arthritis Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rheumatoid Arthritis Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Rheumatoid Arthritis Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others

Segmentation by Application:
Hospitals and Clinics
Diagnostic Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Randox Laboratories
Guangzhou Leide Biosciences
Beijing Diagreat Biotechnologies

Please note: The report will take approximately 2 business days to prepare and deliver.